Summary
31 / 100 · Bulios Score
What speaks for it
- It could repay all its net debt from 0.0 years of operating profit.
- It has been profitable 6 years in a row.
What to watch
- Operating profit does not even cover the interest on its debt.
- Earnings per share fell by 73% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Out of every 100 INR of revenue, only 0.3 INR is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 1,523.9 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (INR)
Diluted EPS (INR)
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 4.5% a year. Earnings per share fell by 73% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 INR of revenue goes
- Cost of sales 75 INR
- Sales and administration 25 INR
- Taxes and other 0.2 INR
- Net profit 0.3 INR
Net profit, industry median (Medical - Care Facilities) 6.8 INR
Out of every 100 INR of revenue, 0.3 INR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail